Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shu Fei Tie for Preventing Recurrence of Asthma and COPD
NCT06691802Not yet recruiting
- Sponsor
- Henan University of Chinese Medicine
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial in asthma and chronic obstructive pulmonary disease (COPD) comparing Shu Fei Tie group with Placebo group (2 arms). Primary endpoints: Number of acute attacks per year for asthma at 3 years, Number of acute exacerbations per year for COPD at 3 years and 2 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
shu fei tie
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06691802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06691802.